Annamycin liposomal - Moleculin Biotech

Drug Profile

Annamycin liposomal - Moleculin Biotech

Alternative Names: Annamycin liposomal - University of Texas M.D. Anderson Cancer Center; Annamycin-LF; L-ANNA; L-annamycin; Liposomal annamycin; S-ANNA

Latest Information Update: 27 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Texas M. D. Anderson Cancer Center
  • Developer Aronex Pharmaceuticals; Callisto Pharmaceuticals; Moleculin Biotech; University of Texas M. D. Anderson Cancer Center
  • Class Anthracyclines; Antineoplastics; Cytostatic antibiotics
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Precursor cell lymphoblastic leukaemia-lymphoma; Acute myeloid leukaemia
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Acute myeloid leukaemia
  • Discontinued Breast cancer; Cancer; Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 27 Feb 2018 Preclinical trials in Acute myeloid leukaemia (Combination therapy) in USA (IV) (Moleculin Biotech pipeline, February 2018)
  • 22 Feb 2018 Phase-I/II clinical trials in Acute myeloid leukaemia (Second-line therapy or greater) in USA (IV) (Moleculin Biotech pipeline, February 2018)
  • 09 Jan 2018 Moleculin Biotech plans a phase I/II trial for Acute myeloid leukaemia, in January 2018 (NCT03388749)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top